Literature DB >> 2240033

Carrier testing and prenatal diagnosis for hemophilia: experiences and attitudes of 549 potential and obligate carriers.

I Varekamp1, T P Suurmeijer, A H Bröcker-Vriends, H van Dijck, C Smit, F R Rosendaal, E Briët.   

Abstract

Experiences with and attitudes toward carrier testing and prenatal diagnosis were evaluated among 549 potential and obligate carriers of hemophilia. Almost everybody considered carrier testing to be useful. Forty-nine percent had been tested for carriership, 10% had only received limited information, and 41% had not been tested and had never received information about the heredity of hemophilia. More married women, women with severe hemophilia in their family, and women closely related to a patient with hemophilia had been tested for carriership than others. Lack of information about the probability of carriership for female relatives and a similar ignorance of the possibility of carrier testing were important reasons for not having been tested. Eleven percent of the women with one or more children had undergone prenatal diagnosis in the past. Thirty-one percent of the study population would favour prenatal diagnosis with the implication of a potential abortion in early pregnancy and half of them would choose this option even in late pregnancy. Most of the women who objected to prenatal diagnosis did so because they did not consider hemophilia to be a sufficiently serious disorder to justify an abortion.

Entities:  

Mesh:

Year:  1990        PMID: 2240033     DOI: 10.1002/ajmg.1320370134

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  12 in total

1.  Genetic testing in asymptomatic minors: background considerations towards ESHG Recommendations.

Authors:  Pascal Borry; Gerry Evers-Kiebooms; Martina C Cornel; Angus Clarke; Kris Dierickx
Journal:  Eur J Hum Genet       Date:  2009-03-11       Impact factor: 4.246

Review 2.  Hemophilia treatment in historical perspective: a review of medical and social developments.

Authors:  F R Rosendaal; C Smit; E Briët
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

3.  Noninvasive detection of F8 int22h-related inversions and sequence variants in maternal plasma of hemophilia carriers.

Authors:  Irena Hudecova; Peiyong Jiang; Joanna Davies; Y M Dennis Lo; Rezan A Kadir; Rossa W K Chiu
Journal:  Blood       Date:  2017-05-10       Impact factor: 22.113

4.  Uptake of Genetic Counseling, Knowledge of Bleeding risks and Psychosocial Impact in a South African Cohort of Female Relatives of People with Hemophilia.

Authors:  Anne Gillham; Brenda Greyling; Tina-Marie Wessels; Bongi Mbele; Rosemarie Schwyzer; Amanda Krause; Johnny Mahlangu
Journal:  J Genet Couns       Date:  2015-04-02       Impact factor: 2.537

5.  Screening for cystic fibrosis. General practitioners should be involved.

Authors:  N Quereshi
Journal:  BMJ       Date:  1994-07-30

6.  "It was a lot Tougher than I Thought It would be". A Qualitative Study on the Changing Nature of Being a Hemophilia Carrier.

Authors:  Charlotte von der Lippe; Jan C Frich; Anna Harris; Kari Nyheim Solbrække
Journal:  J Genet Couns       Date:  2017-05-26       Impact factor: 2.537

Review 7.  The contribution of DNA analysis to carrier detection and prenatal diagnosis of hemophilia A and B.

Authors:  A H Bröcker-Vriends; E Bakker; H H Kanhai; G J van Ommen; P H Reitsma; J J van de Kamp; E Briët
Journal:  Ann Hematol       Date:  1992-01       Impact factor: 3.673

8.  "Family matters": a conceptual framework for genetic testing in children.

Authors:  Allyn McConkie-Rosell; Gail A Spiridigliozzi
Journal:  J Genet Couns       Date:  2004-02       Impact factor: 2.537

9.  Hemophilia during pregnancy.

Authors:  Ran D Goldman; Victor Blanchette; Gideon Koren
Journal:  Can Fam Physician       Date:  2003-12       Impact factor: 3.275

10.  Prenatal hemoglobinopathy screening. IV. Follow-up of women at risk for a child with a clinically significant hemoglobinopathy.

Authors:  S Loader; C J Sutera; S G Segelman; A Kozyra; P T Rowley
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.